Cannabis Report
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor
Search This Board: 
Last Post: 6/18/2018 1:01:41 PM - Followers: 80 - Board type: Free - Posts Today: 0

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

Cannabis Report
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
News News Alert: InspireMD’s CGuard EPS Featured at the SBHCI Congress in Brazil 06/20/2018 07:20:14 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1718  Sticky Note NSPR declined to $1.0 so far! Fortunately it Value_Investor 06/18/18 10:44:44 AM
#1719   Ok. NYK PT 06/18/18 01:01:41 PM
#1718   NSPR declined to $1.0 so far! Fortunately it Value_Investor 06/18/18 10:44:44 AM
#1717   Should trade sideways on monday? NYK PT 06/17/18 12:36:15 PM
#1716   No. It is just a cash-raising Plan to Value_Investor 06/17/18 11:37:07 AM
#1715   Does that mean that there will be 11,500,000 NYK PT 06/17/18 06:09:44 AM
#1714   It is just a "PRELIMINARY PROSPECTUS SUBJECT TO Value_Investor 06/16/18 11:08:12 AM
#1713   What do you think about this? NYK PT 06/16/18 02:35:12 AM
#1712   Another good news for NSPR! The company should Value_Investor 06/15/18 10:54:16 AM
#1711   Dr. Antonio Micari, MD, PhD, Interventional Cardiologist, Maria NYK PT 06/14/18 06:45:12 PM
#1710   Today, new, positive CGuard™ MicroNet™ EPS results were NYK PT 06/14/18 11:59:37 AM
#1709   NSPR had very good news from the company Value_Investor 06/14/18 11:20:02 AM
#1708   Today closed +1.30... NYK PT 06/12/18 10:48:07 AM
#1707   NSPR just hit a new high $1.3 v.s. Value_Investor 06/12/18 10:23:49 AM
#1706   investorshub.advfn.com/uimage/uploads/2018/6/11/ysxjbNSPR.png NYK PT 06/11/18 04:22:30 PM
#1705   let's get there NYK PT 06/11/18 03:05:31 PM
#1704   Let's see ... I also think ... NYK PT 06/11/18 03:03:30 PM
#1703   I'm still finding it hard to believe this Three2001 06/11/18 03:01:10 PM
#1702   NSPR is up 7.83% so far after today's Value_Investor 06/11/18 02:59:12 PM
#1701   $NSPR InspireMD’s CGuard™ MicroNet™ EPS Featured in a NYK PT 06/11/18 12:56:53 PM
#1700   I totally agree with you... NYK PT 06/10/18 02:31:28 PM
#1699   NSPR had very good news from the company Value_Investor 06/10/18 12:39:18 PM
#1698   What do you expect for NSPR in the NYK PT 06/10/18 05:39:11 AM
#1697   As I predicted NSPR did test the previous Value_Investor 06/09/18 04:02:20 PM
#1696   $NSPR Next week can be interesting... NYK PT 06/09/18 03:59:28 AM
#1695   NSPR has good news today --- see the Value_Investor 06/04/18 09:18:36 AM
#1694   http://www.inspiremd.com/en/press-center/inspiremd-reports-expanded-2-year-follo NYK PT 06/04/18 07:37:38 AM
#1693   Let's see what next week brings us ... NYK PT 06/03/18 05:19:16 AM
#1692   Why very good news on May 30, 2018 Value_Investor 06/02/18 06:59:00 PM
#1691   $NSPR: New SEC Filing for NSPR: Form 8-K http://stocknewsflow.com/1433607_000 NYK PT 06/02/18 02:27:14 AM
#1690   Why did NSPR crash to $1.16 today from Value_Investor 06/01/18 04:35:13 PM
#1689   What’s the news? doncamel 06/01/18 12:34:45 PM
#1688   Why did NSPR crash to $1.17 today from Value_Investor 06/01/18 10:10:30 AM
#1687   Lol- agree doncamel 05/30/18 05:02:23 PM
#1686   No, no, no, NO! Three2001 05/30/18 05:00:52 PM
#1685   * * $NSPR Video Chart 05-30-18 * * ClayTrader 05/30/18 04:46:34 PM
#1684   Boom! $NSPR running now. NYK PT 05/30/18 08:28:37 AM
#1683   BOOOOOM !!!! NYK PT 05/30/18 08:24:19 AM
#1682   This is gonna take off much higher this doncamel 05/30/18 07:59:53 AM
#1681   http://www.inspiremd.com/en/press-center/inspiremd-reports-expanded-2-year-follo Termiteous 05/30/18 07:53:18 AM
#1680   End of day volume surge on watch stock1ace1 05/25/18 01:04:00 PM
#1679   $NSPR 1.41 +11%, better follow my DDs. all ash111 05/25/18 12:23:13 PM
#1678   **** Fridays Breakout Play **** Calling All Traders & stock1ace1 05/25/18 11:10:02 AM
#1677   ~> 50 MA Break Clay <~ @1.40 atm stock1ace1 05/25/18 11:08:28 AM
#1676   The current 10-Q report is actually very bad Value_Investor 05/24/18 07:45:02 PM
#1675   $NSPR CGuard™ Clinical Updates today at EuroPCR NYK PT 05/24/18 04:53:29 PM
#1674   THANK YOU NYK PT 05/24/18 02:47:51 PM
#1673   utstanding as of May 4, 2018: 6,449,832 , ash111 05/24/18 02:05:13 PM
#1672   Of how much the flotation is? NYK PT 05/24/18 11:42:35 AM
#1671   I know you did because I used your doncamel 05/24/18 10:40:34 AM
#1670   I know.did my DD. Solid balance sheet. ash111 05/24/18 10:37:02 AM
PostSubject